The complication of coinfection

Yale Journal of Biology and Medicine

Volumn 85, Issue 1, 2012, Pages 127-132

  Pasman, Lesley ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Bacterial pneumonia; Coinfection; Flu; Hiv; Influenza; Mtb; Polymicrobial infection; Secondary infection; Tuberculosis

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; INTERFERON; INTERLEUKIN 10; TOLL LIKE RECEPTOR;

ANTIBODY RESPONSE; B LYMPHOCYTE; BACTERIAL PNEUMONIA; CD4+ T LYMPHOCYTE; COMMENSAL; CONCURRENT INFECTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION COMPLICATION; INFECTION PREVENTION; INFLUENZA; MIXED INFECTION; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; OTITIS MEDIA; RESPIRATORY VIRUS; REVIEW; SECONDARY INFECTION; VIRAL CLEARANCE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; BACTERIAL INFECTIONS; CHRONIC DISEASE; COINFECTION; HIV INFECTIONS; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 84859360692     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. WHO. World Health Organization Report on Infectious Disease: Removing Obstacles to Healthy Development [Internet]. 1999. Available from: http://www.who.int/infectious-disease-report/index-rpt99.html.
2. Bakaletz LO. Developing animal models for polymicrobial diseases. Nature Reviews Microbiology. 2004;2(7):552-68.
3. WHO Public Health Research Agenda for Influenza. Geneva: World Health Organization; 2010. p. 1-19.
4. Cabre M. Pneumonia in the elderly. Curr Opin Pulm Med. 2009;15(3):223-9.
5. Vergison A. Microbiology of otitis media: a moving target. Vaccine. 2008;26(Suppl 7):G5-10.
6. Kwan CK, Ernst JD. HIV and Tuberculosis: a Deadly Human Syndemic. Clin Microbiol Rev. 2011;24(2):351-76.
7. van der Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ. Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications. Crit Care. 2010;14(2):219.
8. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198(7):962-70.
9. CDC. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58(38):1071-4.
10. Dhanoa A, Fang NC, Hassan SS, Kaniappan P, Rajasekaram G. Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection. Virol J. 2011;8:501.
11. Kolata G. FLU: The story of the great influenza pandemic of 1918 and the search for the virus that caused it. New York: Touchstone; 1999.
12. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187(6):1000-9.
13. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192(2):249-57.
14. Kim Y-G, Park J-H, Reimer T, Baker Darren P, Kawai T, Kumar H, et al. Viral Infection Augments Nod1/2 Signaling to Potentiate Lethality Associated with Secondary Bacterial Infections. Cell Host Microbe. 2011;9(6):496-507.
15. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE. 2009;4(12):e8540.
16. Kudva A, Scheller EV, Robinson KM, Crowe CR, Choi SM, Slight SR, et al. Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice. J Immunol. 2011;186(3):1666-74.
17. Mccullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis. 2004;190(3):519-26.
18. Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza Virus-Induced Glucocorticoids Compromise Innate Host Defense against a Secondary Bacterial Infection. Cell Host Microbe. 2010;7(2):103-14.
19. Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008;14(8):1187-92.
20. Chonmaitree T, Revai K, Grady JJ, Clos A, Patel JA, Nair S, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815-23.
21. McGillivary G, Mason KM, Jurcisek JA, Peeples ME, Bakaletz LO. Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cell Microbiol. 2009;11(9):1399-408.
22. van der Sluijs KF, van Elden LJ, Nijhuis M, Schuurman R, Pater JM, Florquin S, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004;172(12):7603-9.
23. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008;205(2):323-9.
24. Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology. 2007;122(4):457-65.
25. Piguet V, Trono D. Living in oblivion: HIV immune evasion. Seminars in Immunology. 2001;13(1):51-7.
26. Douek DC, Roederer M, Koup RA. Emerging Concepts in the Immunopathogenesis of AIDS. Annu Rev Med. 2009;60(1):471-84.
27. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992;89(2):561-6.
28. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med. 1999;5(1):83-9.
29. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev. 1997:187-228.
30. UNAIDS. AIDS epidemic update: November 2009. Geneva, Switzerland: UNAIDS; 2009.
31. Perry S, Hussain R, Parsonnet J. The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunology. 2011;4(3):246-51.
32. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010;207(13):2869-81.
33. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324(23):1644-50.